Bausch Health Companies Inc. (BHC)

18.36 +0.36 (+2.00%) At close: 4:00PM EDT

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
514-744-6792
http://www.bauschhealth.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 21,700

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Joseph C. Papa	CEO & Chairman	4.86M	N/A	1955
Mr. Paul S. Herendeen	Exec. VP & CFO	2.75M	N/A	1956
Ms. Christina M. Ackermann	Exec. VP, Gen. Counsel & Head of Commercial Operations	1.51M	N/A	1965
Mr. Thomas J. Appio	Pres & Co-Head Bausch + Lomb/International	2.09M	N/A	1962
Mr. William D. Humphries	Pres of Ortho-Dermatologics	1.63M	N/A	1966
Mr. Osama A. Eldessouky	Sr. VP, Controller & Chief Accounting Officer	N/A	N/A	1972
Dr. Robert F. Butz	VP of Medical & Scientific Affairs	N/A	N/A	N/A
Mr. Arthur J. Shannon	Sr. VP and Head of Investor Relations & Communications	N/A	N/A	N/A
Mr. Michael McMyne	VP of Sales	N/A	N/A	N/A
Ms. Stacey Williams	VP of Marketing	N/A	N/A	N/A

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Corporate Governance

Bausch Health Companies Inc.’s ISS Governance QualityScore as of October 6, 2020 is 2. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 4; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.